Idenix Names Weidenbruch General Counsel
Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel.
Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel. Before joining Idenix, Weidenbruch served as general counsel at Abraxis BioScience Inc. and in various legal roles at Amgen.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
